Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TCRX | AMGN | VRTX | BMY | GILD |
| Company | Tscan Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 3.02 | 265.18 | 467.06 | 57.35 | 92.72 |
| High | 3.10 | 267.19 | 471.05 | 58.55 | 93.50 |
| Low | 2.95 | 261.50 | 453.24 | 56.94 | 91.18 |
| Last | 2.93 | 261.51 | 453.24 | 57.22 | 91.48 |
| Change | -0.04 | -4.44 | -16.00 | -0.43 | -1.32 |
| % Change | -1.35% | -1.67% | -3.41% | -0.75% | -1.42% |
| Volume | 268,751 | 1,594,442 | 808,044 | 6,978,698 | 2,516,974 |
| 20-Day Average Volume | 450,343 | 4,525,363 | 1,208,228 | 9,379,005 | 6,247,658 |
| Previous Close | 2.97 | 265.95 | 469.24 | 57.65 | 92.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.97 | 277.90 | 462.76 | 58.12 | 91.74 |
| 20-Day Raw Stochastic | 17.52% | 13.71% | 34.36% | 37.94% | 53.05% |
| 20-Day Relative Strength | 33.09% | 29.33% | 44.13% | 52.15% | 52.34% |
| Weighted Alpha | -41.71 | -14.61 | +8.13 | +17.51 | +23.15 |
| Today's Opinion | 100% Sell | 88% Sell | 56% Sell | 80% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 24% Sell | 80% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 40% Sell | 32% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.27% since 12/11/24 | -3.73% since 12/11/24 | -2.67% since 12/11/24 | +0.94% since 12/11/24 | -1.04% since 12/11/24 |
| Low | 2.82 on 12/13/24 | 262.69 on 12/18/24 | 453.72 on 12/18/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 |
| High | 3.15 on 12/17/24 | 275.88 on 12/12/24 | 474.18 on 12/17/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 |
| 1-Month | |||||
| %Chg | -28.33% since 11/18/24 | -5.57% since 11/18/24 | -2.40% since 11/18/24 | +0.67% since 11/18/24 | +3.35% since 11/18/24 |
| Low | 2.60 on 12/11/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 55.04 on 12/13/24 | 86.08 on 11/19/24 |
| High | 4.94 on 11/29/24 | 297.32 on 11/25/24 | 476.46 on 12/10/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | -45.67% since 09/18/24 | -20.94% since 09/18/24 | -3.87% since 09/18/24 | +14.96% since 09/18/24 | +8.98% since 09/18/24 |
| Low | 2.60 on 12/11/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 48.94 on 09/19/24 | 81.83 on 09/26/24 |
| High | 6.22 on 11/07/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -56.63% since 06/18/24 | -13.98% since 06/18/24 | -2.45% since 06/18/24 | +40.11% since 06/18/24 | +44.77% since 06/18/24 |
| Low | 2.60 on 12/11/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 39.35 on 07/05/24 | 64.86 on 06/20/24 |
| High | 7.89 on 07/16/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 158,512 | 142,956,912 | 120,842,896 | 116,924,408 | 115,653,488 |
| Shares Outstanding, K | 53,371 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 21,050,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -89,220,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 1,050,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -29,890,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.79 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 11/12/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/14/24 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.87 | 0.00 | 47.75 | 20.78 |